Journal
MOLECULAR METABOLISM
Volume 3, Issue 3, Pages 241-251Publisher
ELSEVIER
DOI: 10.1016/j.molmet.2013.12.001
Keywords
Oxyntomodulin; Glucagon; GLP-1; Glucose metabolism; Body weight
Categories
Ask authors/readers for more resources
Oxyntomodulin (OXM) is a peptide hormone released from the gut in post-prandial state that activates both the glucagon-like peptide-1 receptor (GLP1R) and the glucagon receptor (GCGR) resulting in superior body weight lowering to selective GLP1R agonists. OXM reduces food intake and increases energy expenditure in humans. While activation of the GCGR increases glucose production posing a hyperglycemic risk, the simultaneous activation of the GLP1R counteracts this effect. Acute OXM infusion improves glucose tolerance in T2DM patients making dual agonists of the GCGR and GLP1R new promising treatments for diabetes and obesity with the potential for weight loss and glucose lowering superior to that of GLP1R agonists. (C) 2013 The Author. Published by Elsevier GmbH. open access under CC BY-NC-ND license
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available